Premium
Naldemedine for the treatment of opioid‐induced constipation
Author(s) -
Chaplin Steve
Publication year - 2021
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1913
Subject(s) - medicine , constipation , opioid , receptor
Naldemedine (Rizmoic) is a peripherally‐acting mu‐opioid receptor antagonist for the treatment of opioid‐induced constipation in adults. This article outlines its indications, efficacy and adverse effects.